• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

A Timeline of 2023 Lab Company Layoffs So Far

A Timeline of 2023 Lab Company Layoffs So Far

by Glenn S. Demby | May 4, 2023 | Inside the Lab Industry-lir, Laboratory Industry Report

The wave of layoffs, which began last year with the declines in COVID-19 testing sales, has gathered momentum in 2023.

This content is for Paid Members only.
Login Register
Lab Institute Virtual Event: Dealing with a Difficult Economy

Lab Institute Virtual Event: Dealing with a Difficult Economy

by G2 Intelligence Staff | Apr 6, 2023 | News, OLP, Webinars

Our June virtual event will offer a variety of solutions and strategies for dealing with key issues labs face during times of economic strife.

FTC Orders Illumina to Unwind Grail Acquisition

FTC Orders Illumina to Unwind Grail Acquisition

by Glenn S. Demby | Apr 5, 2023 | News

On Friday, the US federal trade commission ordered Illumina to divest Grail, which it acquired for $8 billion in August 2021.

Clinical Lab Services Market to Be Worth More than $125.6 Billion by 2030

Clinical Lab Services Market to Be Worth More than $125.6 Billion by 2030

by Rachel Muenz | Mar 15, 2023 | News

A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.

COVID-19 Losses Take a Toll on Q4 Earnings—but It Could Have Been Worse

COVID-19 Losses Take a Toll on Q4 Earnings—but It Could Have Been Worse

by Glenn S. Demby | Feb 28, 2023 | Earnings-lir, Laboratory Industry Report

Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com